FLUOXYMEST 5 MG

Potent oral androgen used in selected androgen-deficiency conditions under medical supervision.

Fluoxymest 5 mg (active pharmaceutical ingredient: Fluoxymesterone, historically known as Halotestin) is an extremely potent, orally active synthetic androgen and anabolic-androgenic steroid (AAS).

Because Fluoxymest 5 mg is primarily manufactured in South Asia (predominantly India) and exported globally, its medical and non-medical purposes vary by region and regulatory framework.

1. Primary Approved Medical Indications (Global Standard)

Where fluoxymesterone is approved by health agencies (such as the US FDA, MHRA in the UK, and CDSCO in India), its medical uses are strictly defined:

1. Male Hypogonadism: Prescribed for men with low or absent natural testosterone production caused by primary testicular failure or secondary pituitary/hypothalamic dysfunction.
2. Delayed Puberty in Males: Used short-term to stimulate growth and sexual development in adolescent males with pathologically delayed puberty.
3. Palliation of Advanced Female Breast Cancer: Used as a second- or third-line hormonal therapy for postmenopausal women with androgen-responsive or metastatic breast cancer.

2. Country-Wise Overview & Distribution

India & South Asia (Country of Origin)

1. Status: Manufactured by generic pharmaceutical.
2. Primary Medical Use: Prescribed under specialist supervision for hypogonadism, severe endocrine deficiency, or specific blood/marrow disorders.
3. Export Market: Widely packaged and distributed for international pharmaceutical trade.

United States & Canada

1. Brand Equivalents: Historically sold under the brand Halotestin or Fluoxymest 5 mg.